Oliver Schnell

Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.

B. Braun Melsungen AG manufactures and distributes pharmaceutical products and medical equipment. Its products are used in the treatment of degenerative spinal diseases, diabetes management, nutritional therapy, extracorporeal blood treatment, laparoscopy, neurosurgery, wound management, and urology. The company was founded on June 23, 1839 and is headquartered in Melsungen, Germany.